The ENDPOINTS 100 Survey

Endpoints News’ first quarterly confidence survey of the global biotech industry surveyed a group of biotech CEOs, C-suite execs and VCs on a variety of biotech boards in the U.S. and Europe. In the survey, they share their views on access to capital, hiring, valuations, the regulatory environment, outsourcing, pricing, and the U.S. presidential election. See how they answered key questions in the interactive charts below:

Read the full survey at endpts.com…